News
NICE okays UCB's Cimzia, nixes Almirall's Ilumetri, in psori...
NICE has recommended in draft guidance that UCB’s Cimzia can receive regular NHS funding for plaque psoriasis, but decided that Almirall’s rival Ilumetri does not represent good value for m
